Eli Lilly and Co.
| Name | Area | Department | Start Year | Stop Year | Advisor |
|---|---|---|---|---|---|
| David Bredt | Neurotransmitters | ||||
| Martin B. Gill | neurodegeneration | 2009 | 2011 | David Bredt (post-doc) | |
| Eric Nisenbaum | Anthony Albert Grace (post-doc) | ||||
| Steven M. Paul | Alcohol, GABA, neurosteroids, dementia |